{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:19:10Z","timestamp":1793726350204,"version":"4.6.1"},"reference-count":49,"publisher":"Galenos Yayinevi","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TJAR"],"published-print":{"date-parts":[[2023,8,1]]},"DOI":"10.4274\/tjar.2023.221093","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T11:58:28Z","timestamp":1692187108000},"page":"280-289","source":"Crossref","is-referenced-by-count":10,"title":["Vasoplegic Syndrome and Anaesthesia: A Narrative Review"],"prefix":"10.4274","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0114-5845","authenticated-orcid":false,"given":"Beg\u00fcm Nemika","family":"G\u00f6kdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-1772","authenticated-orcid":false,"given":"Nedim","family":"\u00c7ekmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018;22(1):174. [CrossRef]","DOI":"10.1186\/s13054-018-2102-1"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Walsh M, Devereaux PJ, Garg AX, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507-515. [CrossRef]","DOI":"10.1097\/ALN.0b013e3182a10e26"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Liu H, Yu L, Yang L, Green MS. Vasoplegic syndrome: An update on perioperative considerations. J Clin Anesth. 2017;40:63-71. [CrossRef]","DOI":"10.1016\/j.jclinane.2017.04.017"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Cai Y, Mack A, Ladlie BL, Martin AK. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery. Ann Card Anaesth. 2017;20(4):462-464. [CrossRef]","DOI":"10.4103\/aca.ACA_88_17"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018;22(1):52. [CrossRef]","DOI":"10.1186\/s13054-018-1967-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Fischer GW, Levin MA. Vasoplegia during cardiac surgery: current concepts and management. Semin Thorac Cardiovasc Surg. 2010;22(2):140-144. [CrossRef]","DOI":"10.1053\/j.semtcvs.2010.09.007"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016;316(5):509-518. [CrossRef]","DOI":"10.1001\/jama.2016.10485"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015;349(1):80-88. [CrossRef]","DOI":"10.1097\/MAJ.0000000000000341"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology. 2017;126(1):85-93. [CrossRef]","DOI":"10.1097\/ALN.0000000000001543"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Shaefi S, Mittel A, Klick J, et al. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy. J Cardiothorac Vasc Anesth. 2018;32(2):1013-1022. [CrossRef]","DOI":"10.1053\/j.jvca.2017.10.032"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020;24(1):36. [CrossRef]","DOI":"10.1186\/s13054-020-2743-8"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Datt V, Wadhhwa R, Sharma V, Virmani S, Minhas HS, Malik S. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management. J Card Surg. 2021;36(10):3749-3760. [CrossRef]","DOI":"10.1111\/jocs.15805"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Weis F, Kilger E, Beiras-Fernandez A, et al. Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia. 2006;61(10):938-942. [CrossRef]","DOI":"10.1111\/j.1365-2044.2006.04779.x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Dur\u00e1n Bruce M, Gomar Sancho C, Holguera JC, Muliterno Espa\u00f1ol E. Factores implicados en el desarrollo de vasoplej\u00eda tras cirug\u00eda cardiaca con circulaci\u00f3n extracorp\u00f3rea. Estudio prospectivo observacional [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study]. Rev Esp Anestesiol Reanim. 2014;61(5):246-253. [CrossRef]","DOI":"10.1016\/j.redar.2013.11.015"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Tsiouris A, Wilson L, Haddadin AS, Yun JJ, Mangi AA. Risk assessment and outcomes of vasoplegia after cardiac surgery. Gen Thorac Cardiovasc Surg. 2017;65(10):557-565. [CrossRef]","DOI":"10.1007\/s11748-017-0789-6"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, Fischer GW. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation. 2009;120(17):1664-1671. [CrossRef]","DOI":"10.1161\/CIRCULATIONAHA.108.814533"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Levick JR. An introduction to cardiovascular physiology. Abingdon: CRC Press; 2011. [CrossRef]","DOI":"10.1201\/9780429300219"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"F\u00f6rstermann U, M\u00fcnzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113(13):1708-1714. [CrossRef]","DOI":"10.1161\/CIRCULATIONAHA.105.602532"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Dorris SL, Peebles RS Jr. PGI2 as a regulator of inflammatory diseases. Mediators Inflamm. 2012;2012:926968. [CrossRef]","DOI":"10.1155\/2012\/926968"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Yeager ME, Belchenko DD, Nguyen CM, Colvin KL, Ivy DD, Stenmark KR. Endothelin-1, the unfolded protein response, and persistent inflammation: role of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 2012;46(1):14-22. [CrossRef]","DOI":"10.1165\/rcmb.2010-0506OC"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Sellers MM, Stallone JN. Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure. Am J Physiol Heart Circ Physiol. 2008;294(5):H1978-H1986. [CrossRef]","DOI":"10.1152\/ajpheart.01318.2007"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Alfirevic A, Xu M, Johnston D, Figueroa P, Koch CG. Transfusion increases the risk for vasoplegia after cardiac operations. Ann Thorac Surg. 2011;92(3):812-819. [CrossRef]","DOI":"10.1016\/j.athoracsur.2011.04.020"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Wagener G, Kovalevskaya G, Minhaz M, Mattis F, Emond JC, Landry DW. Vasopressin deficiency and vasodilatory state in end-stage liver disease. J Cardiothorac Vasc Anesth. 2011;25(4):665-670. [CrossRef]","DOI":"10.1053\/j.jvca.2010.09.018"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Hershman E, Hadash A, Attias O, Ben-Ari J. Methylene blue treatment for resistant shock following renal transplantation. Paediatr Anaesth. 2015;25(11):1168-1169. [CrossRef]","DOI":"10.1111\/pan.12742"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Bezinover D, Kadry Z, Uemura T, et al. Association between plasma cyclic guanosine monophosphate levels and hemodynamic instability during liver transplantation. Liver Transpl. 2013;19(2):191-198. [CrossRef]","DOI":"10.1002\/lt.23570"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gold AK, Patel PA, Lane-Fall M, et al. Cardiovascular Collapse During Liver Transplantation-Echocardiographic-Guided Hemodynamic Rescue and Perioperative Management. J Cardiothorac Vasc Anesth. 2018;32(5):2409-2416. [CrossRef]","DOI":"10.1053\/j.jvca.2018.01.050"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Hosseinian L, Weiner M, Levin MA, Fischer GW. Methylene Blue: Magic Bullet for Vasoplegia? Anesth Analg. 2016;122(1):194-201. [CrossRef]","DOI":"10.1213\/ANE.0000000000001045"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Harrois A, Hamada SR, Duranteau J. Fluid resuscitation and vasopressors in severe trauma patients. Curr Opin Crit Care. 2014;20(6):632-637. [CrossRef]","DOI":"10.1097\/MCC.0000000000000159"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Lundy JB, Chung KK, Pamplin JC, Ainsworth CR, Jeng JC, Friedman BC. Update on Severe Burn Management for the Intensivist. J Intensive Care Med. 2016;31(8):499-510. [CrossRef]","DOI":"10.1177\/0885066615592346"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Cheng X, Tong J, Hu Q, Chen S, Yin Y, Liu Z. Meta-analysis of the effects of preoperative renin-angiotensin system inhibitor therapy on major adverse cardiac events in patients undergoing cardiac surgery. Eur J Cardiothorac Surg. 2015;47(6):958-966. [CrossRef]","DOI":"10.1093\/ejcts\/ezu330"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Guarracino F, Habicher M, Treskatsch S, et al. Vasopressor Therapy in Cardiac Surgery-An Experts' Consensus Statement. J Cardiothorac Vasc Anesth. 2021;35(4):1018-1029. [CrossRef]","DOI":"10.1053\/j.jvca.2020.11.032"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Barnes TJ, Hockstein MA, Jabaley CS. Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies. SAGE Open Med. 2020;8:2050312120935466. [CrossRef]","DOI":"10.1177\/2050312120935466"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017;151(6):1229-1238. [CrossRef]","DOI":"10.1016\/j.chest.2016.11.036"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Mehaffey JH, Johnston LE, Hawkins RB, et al. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival. Ann Thorac Surg. 2017;104(1):36-41. [CrossRef]","DOI":"10.1016\/j.athoracsur.2017.02.057"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Venkatesh B, Finfer S, Cohen J, et al. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018;378(9):797-808. [CrossRef]","DOI":"10.1056\/NEJMoa1705835"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Rudyk O, Phinikaridou A, Prysyazhna O, Burgoyne JR, Botnar RM, Eaton P. Protein kinase G oxidation is a major cause of injury during sepsis. Proc Natl Acad Sci U S A. 2013;110(24):9909-9913. [CrossRef]","DOI":"10.1073\/pnas.1301026110"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Wu F, Wilson JX, Tyml K. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic Biol Med. 2004;37(8):1282-1289. [CrossRef]","DOI":"10.1016\/j.freeradbiomed.2004.06.025"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Wieruszewski PM, Nei SD, Maltais S, Schaff HV, Wittwer ED. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series. A A Pract. 2018;11(4):96-99. [CrossRef]","DOI":"10.1213\/XAA.0000000000000752"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Shah PR, Reynolds PS, Pal N, Tang D, McCarthy H, Spiess BD. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series. Can J Anaesth. 2018;65(5):560-568. [CrossRef]","DOI":"10.1007\/s12630-017-1029-3"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Shapeton AD, Mahmood F, Ortoleva JP. Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use. J Cardiothorac Vasc Anesth. 2019;33(4):894-901. [CrossRef]","DOI":"10.1053\/j.jvca.2018.08.017"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Charles FG, Murray LJ, Giordano C, Spiess BD. Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms. Can J Anaesth. 2019;66(12):1501-1513. [CrossRef]","DOI":"10.1007\/s12630-019-01449-x"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Anandaswamy TC, Rajappa GC, Krishnamachar H. Vasoplegic syndrome during Whipple procedure. J Clin Anesth. 2017;36:151-152. [CrossRef]","DOI":"10.1016\/j.jclinane.2016.10.042"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Egi M, Bellomo R, Langenberg C, et al. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg. 2007;83(2):715-723. [CrossRef]","DOI":"10.1016\/j.athoracsur.2006.08.041"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Gunt C, \u00c7ekmen N. Methylene Blue for Treating Vasoplegic Syndrome During Liver Transplantation: A Bolus Dose or Continuous Infusion? Journal of Case Reports. 2019;9(2):123-127. [CrossRef]","DOI":"10.17659\/01.2019.0032"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Klemm S, Glienke C. 218: Evaluation Of Hydroxocobalamin In Vasoplegia In Cardiac Surgery. Critical Care Med. 2016;44(12):131. [CrossRef]","DOI":"10.1097\/01.ccm.0000508898.30711.31"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Woehlck HJ, Boettcher BT, Lauer KK, et al. Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm. A A Case Rep. 2016;7(12):247-250. [CrossRef]","DOI":"10.1213\/XAA.0000000000000398"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Burnes ML, Boettcher BT, Woehlck HJ, Zundel MT, Iqbal Z, Pagel PS. Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2017;31(3):1012-1014. [CrossRef]","DOI":"10.1053\/j.jvca.2016.08.019"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Boettcher BT, Woehlck HJ, Reck SE, et al. Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation. J Cardiothorac Vasc Anesth. 2017;31(4):1381-1384. [CrossRef]","DOI":"10.1053\/j.jvca.2016.10.011"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Jha AK. Use of Vasopressin in Vasoplegic Syndrome with Reduced Ejection Fraction: Asking for Trouble. Anesthesiology. 2018;128(1):227. [CrossRef]","DOI":"10.1097\/ALN.0000000000001954"}],"container-title":["Turkish Journal of Anaesthesiology and Reanimation"],"original-title":[],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:03:32Z","timestamp":1717679012000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjanaesthesiolreanim.org\/articles\/doi\/TJAR.2023.221093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,1]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.4274\/tjar.2023.221093","relation":{},"ISSN":["1304-0871","1305-614X"],"issn-type":[{"value":"1304-0871","type":"print"},{"value":"1305-614X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}